Actively Recruiting
Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome
Led by Federal Research Institute of Pediatric Hematology, Oncology and Immunology · Updated on 2024-01-10
10
Participants Needed
1
Research Sites
271 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the current study is to evaluate the safety and efficacy of low dose treosulfan based conditioning regimen in HSCT with post-transplant cyclophosphamide in Nijmegen breakage syndrome
CONDITIONS
Official Title
Low Dose Treosulfan Based Conditioning Regimen and PTCy in HSCT for Nijmegen Breakage Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients aged 3 months to less than 21 years
- Diagnosis of Nijmegen Breakage Syndrome
- Eligible for allogeneic hematopoietic stem cell transplantation
- Written informed consent signed by a parent or legal guardian
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
HSCT department
Moscow, Russia
Actively Recruiting
Research Team
D
Dmitry Balashov, MD, PhD
CONTACT
A
Alexandra Laberko, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here